Transgender Persons Clinical Trial
Official title:
Research Participation With Transgender and Gender-Diverse Youth
NCT number | NCT05927350 |
Other study ID # | HM20026635 |
Secondary ID | |
Status | Not yet recruiting |
Phase | |
First received | |
Last updated | |
Start date | June 2024 |
Est. completion date | June 2024 |
Research has historically excluded the participation of transgender and gender-diverse people. The purpose of this research study is to find out about what goes into a transgender and gender-diverse youth's decision to participate in research. The results of this study will be used to improve access to research for transgender and gender-diverse youth and therefore, improve the representation of transgender and gender-diverse youth as research participants in research.
Status | Not yet recruiting |
Enrollment | 250 |
Est. completion date | June 2024 |
Est. primary completion date | June 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 15 Years to 21 Years |
Eligibility | Inclusion Criteria: - Gender identity different then sex assigned at birth - Between the ages 15-21 years Exclusion Criteria: - Gender identity the same as their sex assigned at birth - Younger than 15 years of age, and older than 21 years of age |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Virginia Commonwealth University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quantitative Assessment of Pediatric Research Participation in Transgender Youth | The outcome will be the responses (agree or disagree) to the different items in the Pediatric Research Participation measure. | through study completion, estimated to be 3 months | |
Primary | Qualitative Assessment of Pediatric Research Participation in Transgender Youth | The investigators will implement qualitative analysis to explore transgender and gender-diverse youths experiences with research, and barriers and facilitators to participating in research. Specifically, the outcomes will be themes and supporting quotes. | through study completion, estimated to be 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04036500 -
Transgender Estradiol
|
Early Phase 1 | |
Terminated |
NCT04534881 -
Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen
|
Phase 2 | |
Recruiting |
NCT05469204 -
Effect of Estrogen Treatment on Drug Metabolism and Transport
|
||
Not yet recruiting |
NCT05337865 -
Transgender Observational Performance
|
||
Completed |
NCT04448418 -
The Impact of COVID-19 Outbreak on Trans-population's Health in Italy
|
||
Active, not recruiting |
NCT05116293 -
Effect of Testosterone Treatment on Drug Metabolism and Transport
|
||
Recruiting |
NCT05166083 -
Investigation of the Perceptual and Acoustic Voice in Trans Man
|
||
Recruiting |
NCT04515472 -
Effect of Gender Affirming Hormone Therapy on Glucose Metabolism
|
Early Phase 1 | |
Not yet recruiting |
NCT06177600 -
TransHealthGUIDE: Transforming Health for Gender-Diverse Youth
|
N/A | |
Completed |
NCT03864913 -
Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
|
Early Phase 1 | |
Recruiting |
NCT05924217 -
Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France
|
||
Completed |
NCT05187442 -
The Experiences of Erotic and Sexual Risk of Transgender Men: Exploratory Research Design
|
||
Completed |
NCT03120936 -
The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community
|
Phase 4 | |
Recruiting |
NCT04478760 -
Trans & Non-binary Reference Intervals While on Hormone Therapy Study
|